Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 5.10.2026PRO.MED.CS Praha a.s. (PMP-1)96191MONOSAN 40 mg (tbl 30x40 mg (blis.PVC/Al))5.10.2026R
 5.10.2026PRO.MED.CS Praha a.s. (PMP-1)96188MONOSAN 40 mg (tbl 50x40 mg (blis.PVC/Al))5.10.2026R
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)40534Atoris 10 (tbl flm 90x10 mg (blis.OPA/Al/PVC/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)3497BArisppa 10 mg tablety (tbl 60x10 mg (blis.OPA/Al/PVC/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)08791Amlessa 4 mg/5 mg tablety (tbl 30x4 mg/5 mg (blis.OPA/Al/PVC/Al))5.10.2026R
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)97797KAMIREN XL 4 mg (tbl mod 30x4 mg)5.10.2026R
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)34582Coryol 12,5 (tbl 30x12,5 mg (blis.OPA/Al/PVC/Al))5.10.2026R
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)23022Asolfena 10 mg (tbl flm 30x10 mg (blis.PVC/PVDC/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)79133Elicea 10 mg (tbl flm 28x10 mg (blis. OPA/Al/PVC/Al))5.10.2026O
 5.10.2026Teva B.V. (TEV-NL-4)1236ARaponer 4 mg (tbl plg 84x4 mg (blis.Al/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)7914ACo-Amlessa 2 mg/5 mg/0,625 mg tablety (tbl 30x2 mg/5 mg/0,625 mg (blis.OPA/Al/PVC/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)53273Oprymea 0,18 mg tablety (tbl 30x0,18 mg (blis.Al/Al))5.10.2026O
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)44043Kventiax 300 mg (tbl flm 60x300 mg (blis.PVC/Al))5.10.2026O
 30.9.2026Bayer AG (BYE-4)41543Primovist 0,25 mmol/ ml, injekčný roztok, naplnená injekčná striekačka (sol inj 1x10 ml (striek.inj.napln.skl.))5.10.2026Z
 2.10.2026KRKA, d.d., Novo mesto (KRK-2)79137Elicea 10 mg (tbl flm 60x10 mg (blis. OPA/Al/PVC/Al))5.10.2026O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To